Diabetes CarediacaredcareDiabetes CareDiabetes Care0149-59921935-5548American Diabetes Association212734983041198175410.2337/dc10-1754Original ResearchEpidemiology/Health Services ResearchAssociations Between Concentrations of Vitamin D and Concentrations of Insulin, Glucose, and HbA1c Among Adolescents in the United StatesFordEarl S.MDMPHZhaoGuixiangMDPHDTsaiJamesMDMPHLiChaoyangMDPHDDivision of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GeorgiaCorresponding author: Earl S. Ford, eford@cdc.gov.32011172201134364664810920104122010© 2011 by the American Diabetes Association.Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.OBJECTIVE

Our objective was to examine the associations between concentrations of vitamin D and concentrations of insulin, glucose, and HbA1c in a nationally representative sample of adolescents in the U.S.

RESEARCH DESIGN AND METHODS

We used data for 1,941 adolescents, aged 12–17 years, who participated in the National Health and Nutrition Examination Survey between 2001 and 2006.

RESULTS

Adjusted concentrations of insulin were ~24% lower among male subjects with a concentration of vitamin D ≥75 nmol/L than among male subjects with a concentration of vitamin D <50 nmol/L (P = 0.003). Concentrations of vitamin D were inversely associated with concentrations of glucose only among Mexican American male subjects (P = 0.007). No significant associations between concentrations of vitamin D and HbA1c were detected.

CONCLUSIONS

Our results support an inverse association between concentrations of vitamin D and insulin primarily in adolescent male subjects.

In recent years, the relationships between vitamin D and factors involved in glucose homeostasis have received a great deal of attention. Few studies have been conducted using pediatric samples (13). Because the prevalence of deficient or insufficient vitamin D status is high among children and adolescents in the U.S. and is possibly increasing (4,5), any deleterious effect of suboptimal vitamin D status on glucose homeostasis is of interest, especially in light of concerns about increases in diabetes among youth in the U.S. (6). Most previous studies have used small, selected samples of adolescents. To provide additional insights into the associations between circulating concentrations of vitamin D and concentrations of insulin and glucose, we examined data from a large, representative sample of adolescents that included African Americans and Mexican Americans in the U.S.

RESEARCH DESIGN AND METHODS

We used data from the National Health and Nutrition Examination Survey (NHANES) 2001–2006 (7). The participants were recruited using a multistage, stratified sampling design, which is an efficient approach to obtaining a sample representative of the civilian noninstitutionalized population. The participants were interviewed at home and were invited to attend a mobile examination center, where they were asked to complete additional questionnaires, to undergo various examinations, and to provide a blood sample. The study received approval from the NHANES Institutional Review Board, and participants were asked to sign an informed consent form. Details about the survey can be found elsewhere (7).

Serum concentrations of vitamin D (25-hydroxyvitamin D) were measured using the Diasorin 25-OH-vitamin D assay (Diasorin, Stillwater, MN), a radioimmunoassay (8). We created three categories of vitamin D concentrations: deficiency, <50 nmol/L; insufficiency, 50 to <75 nmol/L; and sufficiency, ≥75 nmol/L (9). The methods used to measure insulin (a Pharmacia insulin radioimmunoassay kit, a Tosoh AIA-PACK IRI, and a Merocodia insulin enzyme-linked immunosorbent assay), glucose (a Cobas Mira chemistry system and a Roche/Hitachi 911 analyzer), and HbA1c (Primus automated high-performance liquid chromatography models CLC330 and CLC385 and an HbA1c 2.2 Plus glycohemoglobin analyzer) are described elsewhere (7).

Covariates included age, sex, race, or ethnicity (white, African American, Mexican American, other Hispanic, or mixed race), leisure-time physical activity, BMI percentiles, supplement use during the past months (yes or no), concentrations of HDL cholesterol and non-HDL cholesterol, and a 6-month sampling period. To estimate physical activity, we calculated an average daily metabolic equivalent task hours index. BMI percentiles were calculated from measured weight and height using the Centers for Disease Control and Prevention’s growth charts.

We limited our analyses to participants aged 12–17 years who attended the morning examination and who had fasted at least 8 h. We excluded participants who had been diagnosed with diabetes. Adjusted mean concentrations of insulin (after log transformation), glucose, and HbA1c were calculated using ANCOVA. The statistical significance of the tests for linear trend of means conducted by using general linear contrasts was assessed with an adjusted Wald F statistic that adjusts for the denominator degrees of freedom. The statistical software SUDAAN was used for the analyses to account for the multistage, stratified sampling design.

RESULTS

During the 6-year study period, 2,070 adolescents, aged 12–17 years, attended the morning examination of the mobile examination center. Data for concentrations of glucose, insulin, and vitamin D were available for 2,028 subjects. After excluding records with missing data for covariates, the final analytic sample comprised 1,941 participants, including 531 whites, 620 African Americans, 632 Mexican Americans, and 158 participants of another race or ethnicity.

The means were 65.9 pmol/L (geometric mean: 50.3 pmol/L), 5.1 mmol/L, 5.2%, and 59 nmol/L for concentrations of insulin, glucose, HbA1c, and vitamin D, respectively. Furthermore, 31.5 ± 2.1% (means ± SE; male subjects 27.4%, female subjects 35.7%) had a concentration of vitamin D <50 nmol/L, 48.3 ± 2.0% (male subjects 49.8%, female subjects 46.6%) had a concentration 50 to <75 nmol/L, and 20.3 ± 1.6% (male subjects 22.7%, female subjects 17.7%) had a concentration ≥75 nmol/L.

Adjusted concentrations of insulin were approximately 24% lower among male subjects with a concentration of vitamin D ≥75 nmol/L than among male subjects with a concentration of vitamin D <50 nmol/L (P = 0.003) (Table 1). Concentrations of vitamin D were inversely associated with concentrations of glucose among Mexican American male subjects (P = 0.007). No significant associations between concentrations of vitamin D and HbA1c were detected.

Unadjusted and adjusted geometric means for concentrations of insulin and means for glucose and HbA1c by levels of concentrations of vitamin D among participants aged 12–17 years, NHANES 2001–2006

nUnadjusted vitamin D (nmol/L)
Vitamin D adjusted for sampling period (nmol/L)
Vitamin D adjusted for multiple covariates (nmol/L)*
<5050 to <75≥75P<5050 to <75≥75P<5050 to <75≥75P
Insulin (pmol/L)
 Total1,94160.150.444.7<0.00160.350.444.5<0.00156.351.247.70.004
 Male subjects1,00060.448.240.7<0.00160.348.240.7<0.00156.748.543.30.003
 Female subjects94159.853.050.80.04060.352.850.20.02155.754.454.70.818
 White subjects53157.551.844.70.01357.651.844.70.01252.851.547.40.172
 African American subjects62059.746.143.30.05360.145.342.80.03357.451.748.10.080
 Mexican American subjects63268.451.344.9<0.00168.051.545.4<0.00162.854.052.30.008
 Male subjects
  White26872.550.240.70.00171.850.141.00.00158.850.244.60.043
  African American34350.240.237.70.07550.439.937.30.05348.244.537.40.033
  Mexican American31367.749.240.3<0.00167.449.340.6<0.00160.951.546.30.005
 Female subjects
  White26348.353.550.50.70148.553.650.10.77646.953.052.70.236
  African American27769.357.378.60.77369.755.977.10.80868.958.678.40.677
  Mexican American31969.154.258.90.30168.554.760.10.34965.557.563.30.726
Glucose (mmol/L)
 Total1,9415.15.15.10.4695.15.15.10.8065.15.15.10.457
 Male subjects1,0005.25.25.20.8475.25.25.20.9935.25.25.20.710
 Female subjects9414.95.04.90.8625.05.04.90.5035.05.04.90.401
 White subjects5315.15.15.10.8125.15.15.10.9825.15.15.10.728
 African American subjects6205.04.94.90.3975.04.94.90.3215.04.94.80.095
 Mexican American subjects6325.25.15.10.1195.25.15.10.0725.25.15.00.012
 Male subjects
  White2685.35.25.20.9165.35.25.20.8415.25.25.20.973
  African American3435.15.04.90.0725.15.04.90.0715.15.04.90.098
  Mexican American3135.45.25.20.0095.45.25.20.0035.45.25.20.007
 Female subjects
  White2634.95.04.90.7305.05.04.90.5915.05.04.90.584
  African American2774.94.84.80.9074.94.84.80.7894.94.84.80.706
  Mexican American3195.15.04.90.1505.15.04.90.1595.15.04.90.258
HbA1c (%)
 Total1,9415.25.25.20.4715.25.25.20.2865.25.25.20.626
 Male subjects1,0005.25.25.20.8035.25.25.21.0005.25.25.20.187
 Female subjects9415.25.25.10.2275.25.15.10.0865.25.25.20.694
 White subjects5315.15.25.20.2825.15.25.20.3645.15.25.20.487
 African American subjects6205.35.35.20.5785.35.35.20.5525.35.35.20.427
 Mexican American subjects6325.25.25.20.5625.25.25.20.8325.25.25.20.621
 Male subjects
  White2685.15.25.20.2875.15.25.20.2085.15.25.20.182
  African American3435.35.35.20.5875.35.35.20.5755.35.45.20.596
  Mexican American3135.25.25.20.8155.25.25.20.6765.25.25.20.600
 Female subjects
  White2635.15.15.10.9065.15.25.10.9105.15.15.10.899
  African American2775.35.25.10.4935.35.25.10.4435.35.25.10.298
  Mexican American3195.15.25.10.8915.15.25.10.9055.15.25.20.851

*Adjusted for age; sex; race, or ethnicity; leisure-time physical activity; 30-day use of vitamins, minerals, or other dietary supplements; BMI percentile; HDL cholesterol; non-HDL cholesterol; and examination period. Examination period was a dichotomous variable representing the two 6-month periods of 1 November through 30 April and 1 May through 31 October.

P value for adjusted Wald F test for linear contrast.

CONCLUSIONS

After adjusting for covariates, we found significant inverse associations between concentrations of vitamin D and insulin among adolescent male subjects but not female subjects. Several previous reports have noted inverse relationships between concentrations of vitamin D and surrogate measures of insulin resistance in samples of obese adolescents (1,2) and in a population-based sample of children and adolescents (3). Studies in animals and humans suggest that vitamin D status affects insulin secretion (10), vitamin D receptor expression (11), and tyrosine phosphorylation of insulin receptor substrate 1 (12).

The large, nationally representative sample of adolescents represents an important strength of our study. Several limitations deserve to be acknowledged. The cross-sectional study design precludes establishing causality. The possible effect of the use of different methods to measure concentrations of insulin, glucose, and HbA1c during the various survey cycles on our results is unclear. Concern has been expressed about possible assay variability for the vitamin D assay in the NHANES (13). However, the apparent impact on vitamin D parameters for the period of 2000–2004 was small (14). We were unable to adjust for Tanner stage because this information was not collected.

Prospective studies and clinical trials are needed to clarify the relationships between concentrations of vitamin D and factors involved in glucose homeostasis. Studies using gold-standard techniques to assess insulin resistance also would yield valuable insights. The possibility that vitamin D may affect insulin resistance has potential implications for testing vitamin D concentrations in children and adolescents; recommendations regarding the use of vitamin D supplements and sun exposure, especially in populations at risk for insulin resistance; and fortification of foods. The prevalence of vitamin D deficiency and insufficiency is substantial among adolescents in the U.S.; ~2% of adolescents had concentrations of vitamin D <27 nmol/L, 14% had concentrations <50 nmol/L, and 33% had a concentration ≥75 nmol/L during 2001–2004 (4,5).

Acknowledgments

No potential conflicts of interest relevant to this article were reported.

E.S.F. researched data and wrote the manuscript. G.Z. researched data, contributed to the discussion, and reviewed and edited the manuscript. J.T. contributed to the discussion and reviewed and edited the manuscript. C.L. contributed to the discussion and reviewed and edited the manuscript.

ReferencesAlemzadehRKichlerJBabarGCalhounM Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 2008;57:18319118191047AshrafAAlvarezJSaenzKGowerBMcCormickKFranklinF Threshold for effects of vitamin D deficiency on glucose metabolism in obese female African-American adolescents. J Clin Endocrinol Metab 2009;94:3200320619549742DelvinEELambertMLevyE Vitamin D status is modestly associated with glycemia and indicators of lipid metabolism in French-Canadian children and adolescents. J Nutr 2010;140:98799120237070SaintongeSBangHGerberLM Implications of a new definition of vitamin D deficiency in a multiracial us adolescent population: the National Health and Nutrition Examination Survey III. Pediatrics 2009;123:79780319255005GindeAALiuMCCamargoCAJr Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009;169:62663219307527Fagot-CampagnaAPettittDJEngelgauMM Type 2 diabetes among North American children and adolescents: an epidemiologic review and a public health perspective. J Pediatr 2000;136:66467210802501Centers for Disease Control and Prevention. About the National Health and Nutrition Examination Survey [article online], 2009. Available at http://www.cdc.gov/nchs/nhanes/about_nhanes.htm Accessed 1 December 2010Centers for Disease Control and Prevention. NHANES 2005-2006 data documentation: laboratory assessment: vitamin D [article online], 2009. Available at http://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/vid_d.pdf Accessed 1 December 2010HolickMF Vitamin D deficiency. N Engl J Med 2007;357:26628117634462TaiKNeedAGHorowitzMChapmanIM Vitamin D, glucose, insulin, and insulin sensitivity. Nutrition 2008;24:27928518187309MaestroBCampiónJDávilaNCalleC Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 2000;47:38339111075718ZhouQGHouFFGuoZJLiangMWangGBZhangX 1,25-Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells. Diabetes Metab Res Rev 2008;24:45946418551686Centers for Disease Control and Prevention. Analytical note for NHANES 2000-2006 and NHANES III (1988-1994): 25-hydroxyvitamin D analysis [article online], 2010. Available at http://www.cdc.gov/nchs/data/nhanes/nhanes3/VitaminD_analyticnote.pdf Accessed 1 December 2010LookerACLacherDAPfeifferCMSchleicherRLPiccianoMFYetleyEA Data advisory with regard to NHANES serum 25-hydroxyvitamin D data. Am J Clin Nutr 2009;90:69519571227